抗凝固拮抗薬の世界市場：COVID-19影響分析、製品別、流通チャネル別、国別、地域別 - 業界分析、市場規模、市場シェア、予測（2023年～2030年）

世界の抗凝固拮抗薬の市場規模は、2022年に7億8,050万米ドルとなり、2023年～2030年の間に15.5%のCAGRで成長すると予測されています。

当レポートでは、世界の抗凝固拮抗薬市場について調査分析し、市場概要、市場動向、セグメント別・地域別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 抗凝固拮抗薬市場概要

第2章 エグゼクティブサマリー

第3章 抗凝固拮抗薬の主要な市場動向

• 市場促進要因
  • 市場促進要因の影響分析
• 市場抑制要因
  • 市場抑制要因の影響分析
• 市場機会
• 市場の今後の動向

第4章 抗凝固拮抗薬業界の調査

• PEST分析
• ポーターのファイブフォース分析
• 成長予測のマッピング
• 規制の枠組み分析

第5章 抗凝固拮抗薬市場：COVID-19の影響分析

• COVID-19以前の影響分析
• COVID-19以後の影響分析

第6章 抗凝固拮抗薬市場情勢

• 市場シェア分析（2022年）
• 内訳データ：主要メーカー別
  • 既存企業の分析
  • 新興企業の分析

第7章 抗凝固拮抗薬市場：製品別

• 概要

第8章 抗凝固拮抗薬市場：流通チャネル別

• 概要

第9章 抗凝固拮抗薬市場：地域別

• イントロダクション
• 北米
• 欧州
• アジア太平洋（APAC）
• ラテンアメリカ
• 中東・アフリカ

第10章 主要ベンダー分析：抗凝固拮抗薬業界

• 競合ダッシュボード
• 企業プロファイル
  • Bristol-Myers Squibb Company
  • AstraZeneca
  • Pfizer Inc.
  • Dr. Reddy's Laboratories Ltd
  • Teva Pharmaceutical Industries Ltd
  • Endo International plc
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Mylan N.V.
  • Lupin
  • Cipla Inc
  • Aurobindo Pharma
  • Sanofi
  • Merck & Co. Inc
  • Amneal Pharmaceuticals LLC.
  • Alvogen

第11章 アナリストの全方位展望

第12章 付録

List of Tables

• TABLE List of data sources
• TABLE Market drivers; Impact Analysis
• TABLE Market restraints; Impact Analysis
• TABLE Anticoagulant Reversal Drugs Market:Product Snapshot (2022)
• TABLE Segment Dashboard; Definition and Scope, by Product
• TABLE Global Anticoagulant Reversal Drugs Market, by Product 2018-2030 (USD Million)
• TABLE Anticoagulant Reversal Drugs Market: Regional snapshot (2022)
• TABLE Anticoagulant Reversal Drugs Market: Distribution Channel Snapshot (2022)
• TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
• TABLE Global Anticoagulant Reversal Drugs Market, by Distribution Channel 2018-2030 (USD Million)
• TABLE Segment Dashboard; Definition and Scope, by Region
• TABLE Global Anticoagulant Reversal Drugs Market, by Region 2018-2030 (USD Million)
• TABLE North America Anticoagulant Reversal Drugs Market, by Country, 2018-2030 (USD Million)
• TABLE North America Anticoagulant Reversal Drugs Market, by Product, 2018-2030 (USD Million)
• TABLE North America Anticoagulant Reversal Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
• TABLE Europe Anticoagulant Reversal Drugs Market, by Country, 2018-2030 (USD Million)
• TABLE Europe Anticoagulant Reversal Drugs Market, by Product, 2018-2030 (USD Million)
• TABLE Europe Anticoagulant Reversal Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
• TABLE Asia Pacific Anticoagulant Reversal Drugs Market, by Country, 2018-2030 (USD Million)
• TABLE Asia Pacific Anticoagulant Reversal Drugs Market, by Product, 2018-2030 (USD Million)
• TABLE Asia Pacific Anticoagulant Reversal Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
• TABLE Latin America Anticoagulant Reversal Drugs Market, by Country, 2018-2030 (USD Million)
• TABLE Latin America Anticoagulant Reversal Drugs Market, by Product, 2018-2030 (USD Million)
• TABLE Latin America Anticoagulant Reversal Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
• TABLE Middle East and Africa Anticoagulant Reversal Drugs Market, by Country, 2018-2030 (USD Million)
• TABLE Middle East and Africa Anticoagulant Reversal Drugs Market, by Product, 2018-2030 (USD Million)
• TABLE Middle East and Africa Anticoagulant Reversal Drugs Market, by Distribution Channel, 2018-2030 (USD Million)
• TABLE Middle East and Africa Anticoagulant Reversal Drugs Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

• FIGURE Anticoagulant Reversal Drugs Market Segmentation
• FIGURE Market research methodology
• FIGURE Value chain analysis
• FIGURE Porter's Five Forces Analysis
• FIGURE Market Attractiveness Analysis
• FIGURE COVID-19 Impact Analysis
• FIGURE Pre & Post COVID-19 Impact Comparision Study
• FIGURE Competitive Landscape; Key company market share analysis, 2022
• FIGURE Product segment market share analysis, 2022 & 2030
• FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Distribution Channel segment market share analysis, 2022 & 2030
• FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Distribution Channel segment market share analysis, 2022 & 2030
• FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Regional segment market share analysis, 2022 & 2030
• FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE North America Anticoagulant Reversal Drugs Market share and leading players, 2022
• FIGURE Europe Anticoagulant Reversal Drugs Market share and leading players, 2022
• FIGURE Asia Pacific Anticoagulant Reversal Drugs Market share and leading players, 2022
• FIGURE Latin America Anticoagulant Reversal Drugs Market share and leading players, 2022
• FIGURE Middle East and Africa Anticoagulant Reversal Drugs Market share and leading players, 2022
• FIGURE North America market share analysis by country, 2022
• FIGURE U.S. Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Canada Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Europe Anticoagulant Reversal Drugs Market share analysis by country, 2022
• FIGURE Germany Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Spain Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Italy Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE France Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE UK Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Russia Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Netherlands Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Sweden Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Poland Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Rest of the Europe Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Asia Pacific Anticoagulant Reversal Drugs Market share analysis by country, 2022
• FIGURE India Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE China Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Japan Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE South Korea Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Australia Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Thailand Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Indonesia Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Phillipines Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Rest of APAC Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Latin America Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Latin America Anticoagulant Reversal Drugs Market share analysis by country, 2022
• FIGURE Brazil Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Mexico Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Argentina Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Colombia Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Rest of LATAM Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Middle East and Africa Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Middle East and Africa Anticoagulant Reversal Drugs Market share analysis by country, 2022
• FIGURE Saudi Arabia Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE United Arab Emirates Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Israel Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Turkey Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Algeria Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Egypt Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
• FIGURE Rest of MEA Anticoagulant Reversal Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)

REPORT HIGHLIGHT

Anticoagulant Reversal Drugs Market size was valued at USD 780.5 Million in 2022, expanding at a CAGR of 15.5% from 2023 to 2030.

Anticoagulant drugs, also known as blood thinners, are drugs that reduce or prevent blood coagulation and are frequently used to treat thrombosis. Drugs used to reverse the effects of anticoagulants, such as Idarucizumab, are administered when a bleeding complication or anticoagulant overdose develops. In some circumstances, such as unexpected surgery, anticoagulant therapy overdoses, and uncontrolled bleeding, anticoagulant reversal medications are necessary to counteract the effects of anticoagulation.

Anticoagulant Reversal Drugs Market- Market Dynamics:

People are now more likely to have bleeding problems than before. One of the most prevalent diseases, gastrointestinal (GI) hemorrhage accounts for about 50% of major bleeding episodes. Another serious condition that is getting more common among DOAC patients is intracranial bleeding (ICH). (Direct-acting Oral Anticoagulants). In addition, a rise in the geriatric population, a rise in sedentary lifestyle adoption, and an increase in heart attack instances all contribute to the market's expansion. The frequency of bleeding disorders that lead to abnormal blood coagulation, such as atrial fibrillation (AFib), Von Willebrand disease (VWD), anemia, and others are also rising, which in turn increases the demand for anticoagulant reversal drugs.

Globally, healthcare infrastructure changes and ongoing technological advancements are setting the standard. This is primarily attributable to the outstanding R&D projects carried out by prestigious companies to successfully renovate and enhance the laboratory clinics for various drug discovery and drug testing processes. The U.S. Centers for Medicare and Medicaid Services (CMS) have given specific medications that are specifically made to interact with a few anticoagulants the new technology add-on payment (NTAP) designation. The patient's access to medications with supplemental Medicare reimbursement in hospitals and clinics is significantly improved by this classification.

Anticoagulant Reversal Drugs Market- Segment Analysis

Based on the product, the idarucizumab segment is expected to dominate the market during the forecast period. Idarucizumab's strong revenue generation in important regions is responsible for this. The market is divided into prothrombin complex concentrates, phytonadione (vitamin K), andexanet alfa, idarucizumab, protamine, and others based on the sort of product.

Based on the distribution channel, the hospital segment is expected to dominate the market during the forecast period. This is explained by the fact that hospitals are the primary facilities for the detection and management of various kinds of bleeding disorders. The segment is being driven even more by uncontrolled bleeding in emergencies.

Anticoagulant Reversal Drugs Market- Geographical Insights:

North America is expected to dominate the market during the forecast period. The rising number of surgeries, the increase in the geriatric population, and the region's favorable approval of drugs for life-threatening bleeding disorders are the primary drivers of this market's expansion. Additionally, there are improved healthcare infrastructure options available, and leading market players are doing more R&D. Moreover, during the forecast period, the market for anticoagulant reversal drugs will grow due to high healthcare spending and patient-friendly reimbursement policies for expensive or unaffordable medications.

Anticoagulant Reversal Drugs Market- Recent Development:

In March 2022, for patients taking the Factor Xa inhibitors rivaroxaban, apixaban, or edoxaban, where reversal of anticoagulation is crucial due to lethal or excessive bleeding, Ondexxya became the first reversal agent to be authorized in Japan. The Japanese Ministry of Health, Labour, and Welfare approved the drug as a result of the encouraging findings from the ANNEXA-4 Phase III clinical trial, which showed Ondexxya significantly reversed anti-FXa activity in patients who experienced fatal bleeding. Japan also made history by facilitating Ondexxya's full regulatory clearance for use. This offers a significant improvement in the diagnosis of hospitalized patients with pernicious bleeding.

Key features of the study:

This proposed research study on the Anticoagulant Reversal Drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains an attractive investment proposition matrix for ` the Anticoagulant Reversal Drugs market

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain the Anticoagulant Reversal Drugs market

The impact of COVID-19 on the Anticoagulant Reversal Drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight into the Anticoagulant Reversal Drugs market post-COVID will also be covered.

To give the users of this report a comprehensive view of the Anticoagulant Reversal Drugs market, we have also included a competitive landscape and key innovator analysis for the Anticoagulant Reversal Drugs market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offers detailed company profiling featuring major market participants which will help users to understand the financial information and strategic initiatives of players operating in the Anticoagulant Reversal Drugs market.

In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launches, research & development, and regional expansion of major participants involved in the market on global as well as regional levels.

The global Anticoagulant Reversal Drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET KEY PLAYERS:

Bristol-Myers Squibb Company

AstraZeneca

Pfizer Inc.

Dr. Reddy's Laboratories Ltd

Teva Pharmaceutical Industries Ltd

Endo International plc

Sun Pharmaceutical Industries Ltd

Novartis AG

Mylan N.V.

Lupin

Cipla Inc

Aurobindo Pharma

Sanofi

Merck & Co. Inc

Amneal Pharmaceuticals LLC.

Alvogen

GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, BY PRODUCT:

Prothrombin Complex Concentrates

Phytonadione

Andexanet Alfa

Idarucizumab

Protamine

Others

GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, BY DISTRIBUTION CHANNEL:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

GLOBAL ANTICOAGULANT REVERSAL DRUGS MARKET, BY REGION:

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Russia

Netherlands

Sweden

Poland

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Australia

Thailand

Indonesia

Philippines

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Colombia

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Israel

Turkey

Algeria

Egypt

Rest of MEA

TABLE OF CONTENT

1. Anticoagulant Reversal Drugs Market Overview

• 1.1. Study Scope

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Anticoagulant Reversal Drugs Market Snippet by Product
  • 2.1.2. Anticoagulant Reversal Drugs Market Snippet by Distribution Channel
  • 2.1.3. Anticoagulant Reversal Drugs Market Snippet by Country
  • 2.1.4. Anticoagulant Reversal Drugs Market Snippet by Region
• 2.2. Competitive Insights

3. Anticoagulant Reversal Drugs Key Market Trends

• 3.1. Anticoagulant Reversal Drugs Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Anticoagulant Reversal Drugs Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Anticoagulant Reversal Drugs Market Opportunities
• 3.4. Anticoagulant Reversal Drugs Market Future Trends

4. Anticoagulant Reversal Drugs Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Anticoagulant Reversal Drugs Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Anticoagulant Reversal Drugs Market Landscape

• 6.1. Anticoagulant Reversal Drugs Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Anticoagulant Reversal Drugs Market - By Product

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
  • 7.1.2. Prothrombin Complex Concentrates
  • 7.1.3. Phytonadione
  • 7.1.4. Andexanet Alfa
  • 7.1.5. Idarucizumab
  • 7.1.6. Protamine
  • 7.1.7. Others

8. Anticoagulant Reversal Drugs Market - By Distribution Channel

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
  • 8.1.2. Hospital Pharmacy
  • 8.1.3. Retail Pharmacy
  • 8.1.4. Online Pharmacy

9. Anticoagulant Reversal Drugs Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. Anticoagulant Reversal Drugs Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. Anticoagulant Reversal Drugs Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.3.7. Italy
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.7.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.7.4. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.3.8. United Kingdom
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.8.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.8.4. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.3.9. France
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.9.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.9.4. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.3.10. Russia
    • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.10.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.10.3. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.3.11. Netherlands
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.11.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.11.3. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.3.12. Sweden
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.12.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.12.3. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.3.13. Poland
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.13.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.13.3. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.3.14. Rest of Europe
    • 9.3.14.1. Overview
    • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. Anticoagulant Reversal Drugs Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.4.8. Japan
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.8.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.8.4. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.4.9. South Korea
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.9.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.9.4. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. Anticoagulant Reversal Drugs Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. Anticoagulant Reversal Drugs Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Anticoagulant Reversal Drugs Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. Bristol-Myers Squibb Company
  • 10.2.2. AstraZeneca
  • 10.2.3. Pfizer Inc.
  • 10.2.4. Dr. Reddy's Laboratories Ltd
  • 10.2.5. Teva Pharmaceutical Industries Ltd
  • 10.2.6. Endo International plc
  • 10.2.7. Sun Pharmaceutical Industries Ltd
  • 10.2.8. Novartis AG
  • 10.2.9. Mylan N.V.
  • 10.2.10. Lupin
  • 10.2.11. Cipla Inc
  • 10.2.12. Aurobindo Pharma
  • 10.2.13. Sanofi
  • 10.2.14. Merck & Co. Inc
  • 10.2.15. Amneal Pharmaceuticals LLC.
  • 10.2.16. Alvogen

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us